摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1-叠氮基-4-苯基-1,4-丁二酮 | 846558-24-5

中文名称
1-叠氮基-4-苯基-1,4-丁二酮
中文别名
——
英文名称
1-azido-4-phenyl-1,4-butanedione
英文别名
4-Oxo-4-phenylbutanoyl azide
1-叠氮基-4-苯基-1,4-丁二酮化学式
CAS
846558-24-5
化学式
C10H9N3O2
mdl
——
分子量
203.2
InChiKey
MKOGIUDCTFXQOO-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.6
  • 重原子数:
    15
  • 可旋转键数:
    4
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.2
  • 拓扑面积:
    48.5
  • 氢给体数:
    0
  • 氢受体数:
    3

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    1-叠氮基-4-苯基-1,4-丁二酮一水合肼 作用下, 以 为溶剂, 反应 1.0h, 以92%的产率得到N1,N2-bis(3-oxo-3-phenylpropyl)-1,2-hydrazinodicarboxamide
    参考文献:
    名称:
    Abdel-Fattah, A. A.; Nasar, S. A.; El-Shenawy, A. I., Egyptian Journal of Chemistry, 2003, vol. 46, # 1, p. 153 - 162
    摘要:
    DOI:
  • 作为产物:
    描述:
    3-苯丙烯溴酸酯叠氮磷酸二苯酯三乙胺 作用下, 以 二氯甲烷 为溶剂, 反应 2.5h, 生成 1-叠氮基-4-苯基-1,4-丁二酮
    参考文献:
    名称:
    Orally active .beta.-lactam inhibitors of human leukocyte elastase-1. Activity of 3,3-diethyl-2-azetidinones
    摘要:
    A thorough analysis of the mechanism of inhibition of human leukocyte elastase (HLE) by a monocyclic beta-lactam and the mechanism of beta-lactam hydrolysis led to the preparation of potent and highly stable inhibitors of HLE. This work led to the identification of 4-[(4-carboxyphenyl)-oxy]-3,3-diethyl-1-[[(phenylmethyl)amino]carbonyl]-2-azetidinone (2) as the first orally active inhibitor of human leukocyte elastase (HLE). Analogs of 2 with different substituents on the urea N were synthesized and evaluated for their activity in vitro against HLE as well as in vivo in a hamster lung hemorrhage model. Compounds with a methyl or a methoxy group in the para position of the benzene ring were very potent in both assays. The results are discussed on the basis of the proposed model for the binding of this class of inhibitors to HLE and a possible mechanism of inhibition is presented.
    DOI:
    10.1021/jm00099a003
点击查看最新优质反应信息

文献信息

  • Novel Synthetic Route to Fluoxetine
    作者:Matthias Schulze
    DOI:10.1080/00397910903422518
    日期:2010.10.20
    Racemic fluoxetine was synthesized from 3-benzoylpropionic acid in five steps in 54% overall yield.
    外消旋氟西汀由 3-苯甲酰丙酸分五步合成,总产率为 54%。
  • Orally active .beta.-lactam inhibitors of human leukocyte elastase-1. Activity of 3,3-diethyl-2-azetidinones
    作者:Shrenik K. Shah、Conrad P. Dorn、Paul E. Finke、Jeffrey J. Hale、William K. Hagmann、Karen A. Brause、Gilbert O. Chandler、Amy L. Kissinger、Bonnie M. Ashe
    DOI:10.1021/jm00099a003
    日期:1992.10
    A thorough analysis of the mechanism of inhibition of human leukocyte elastase (HLE) by a monocyclic beta-lactam and the mechanism of beta-lactam hydrolysis led to the preparation of potent and highly stable inhibitors of HLE. This work led to the identification of 4-[(4-carboxyphenyl)-oxy]-3,3-diethyl-1-[[(phenylmethyl)amino]carbonyl]-2-azetidinone (2) as the first orally active inhibitor of human leukocyte elastase (HLE). Analogs of 2 with different substituents on the urea N were synthesized and evaluated for their activity in vitro against HLE as well as in vivo in a hamster lung hemorrhage model. Compounds with a methyl or a methoxy group in the para position of the benzene ring were very potent in both assays. The results are discussed on the basis of the proposed model for the binding of this class of inhibitors to HLE and a possible mechanism of inhibition is presented.
  • Abdel-Fattah, A. A.; Nasar, S. A.; El-Shenawy, A. I., Egyptian Journal of Chemistry, 2003, vol. 46, # 1, p. 153 - 162
    作者:Abdel-Fattah, A. A.、Nasar, S. A.、El-Shenawy, A. I.
    DOI:——
    日期:——
查看更多